S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
S&P 500   3,768.47 (-1.34%)
DOW   30,924.14 (-1.11%)
QQQ   304.10 (-1.64%)
AAPL   120.13 (-1.58%)
MSFT   226.73 (-0.36%)
FB   257.64 (+0.87%)
GOOGL   2,033.93 (+1.12%)
TSLA   621.44 (-4.86%)
AMZN   2,977.57 (-0.91%)
NVDA   494.81 (-3.39%)
BABA   230.50 (-2.44%)
CGC   31.01 (-6.71%)
GE   13.57 (+0.97%)
MU   84.33 (-5.36%)
NIO   39.28 (-5.42%)
AMD   77.75 (-3.85%)
T   28.92 (+0.70%)
F   11.93 (-1.97%)
ACB   9.82 (-6.12%)
DIS   188.03 (-2.20%)
BA   224.71 (-1.68%)
NFLX   511.29 (-1.81%)
BAC   36.50 (+0.22%)
Log in
NASDAQ:ORMP

Oramed Pharmaceuticals Earnings Date, Estimates & History

$7.51
-1.29 (-14.66 %)
(As of 03/4/2021 05:12 PM ET)
Add
Compare
Today's Range
$7.50
Now: $7.51
$8.55
50-Day Range
$4.31
MA: $8.18
$11.33
52-Week Range
$2.40
Now: $7.51
$11.71
Volume1.11 million shs
Average Volume731,714 shs
Market Capitalization$220.57 million
P/E RatioN/A
Dividend YieldN/A
Beta1.98

Earnings

Oramed Pharmaceuticals (NASDAQ:ORMP) Earnings Information

Oramed Pharmaceuticals last posted its quarterly earnings data on January 13th, 2021. The biotechnology company reported ($0.23) earnings per share for the quarter, missing analysts' consensus estimates of ($0.15) by $0.09. The business had revenue of $0.67 million for the quarter. Oramed Pharmaceuticals has generated ($0.56) earnings per share over the last year. Oramed Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, April 5th, 2021 based off prior year's report dates.

Oramed Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Oramed Pharmaceuticals (NASDAQ:ORMP) Earnings Estimates

Current Year EPS Consensus Estimate: $-0.94 EPS
Next Year EPS Consensus Estimate: $-0.95 EPS

Oramed Pharmaceuticals (NASDAQ ORMP) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
4/5/2021
(Estimated)
       
1/13/2021Q1($0.1450)($0.23)($0.23)$0.67 millionN/A
11/23/2020Q4($0.2070)($0.12)($0.12)$0.69 million$0.68 millionN/A
7/7/2020Q3($0.1680)($0.10)($0.10)$0.69 million$0.68 millionN/A
4/6/2020Q2 2020($0.25)($0.21)($0.21)$0.67 millionN/A
1/9/2020Q1($0.26)($0.15)($0.15)$0.67 millionN/A
11/27/2019Q4 2019($0.34)$0.13$0.13$0.65 million$0.68 millionN/A
7/10/2019Q3 2019($0.23)($0.23)($0.23)$0.71 million$0.68 millionN/A
4/10/2019Q2 2019($0.24)($0.21)($0.21)$0.72 million$0.67 millionN/A
1/14/2019Q1 2019($0.25)($0.25)$0.67 millionN/A
11/28/2018Q4 2018($0.28)($0.18)($0.18)$0.62 millionN/A
7/12/2018Q3 2018($0.27)($0.30)($0.30)$0.61 million$0.62 millionN/A
4/8/2018Q2 2018($0.31)($0.20)($0.20)$0.62 million$0.60 millionN/A
1/11/2018Q1 2018($0.24)($0.18)($0.18)$0.62 million$0.61 millionN/A
11/29/2017Q4 2017($0.20)($0.20)$4.29 millionN/A
7/6/2017Q3 2017($0.27)($0.15)($0.15)$0.61 million$0.62 millionN/A
4/5/2017Q2 2017($0.19)($0.24)($0.24)$0.60 million$0.61 millionN/A
1/11/2017Q1 2017($0.20)($0.20)$0.61 millionN/A
11/25/2016Q4 2016($0.37)($0.37)$0.19 million($0.93) millionN/A
7/6/2016Q3 2016($0.19)($0.15)($0.15)$0.20 million$0.16 millionN/A
4/6/2016Q2 2016($0.19)($0.14)($0.14)$0.20 million$0.13 millionN/A
1/13/2016Q1 2016($0.19)($0.21)($0.21)N/A
11/25/2015Q4 2015($0.17)($0.19)($0.19)N/A
7/1/2015Q3 2015($0.21)($0.15)($0.15)N/A
4/3/2015Q2 2015($0.15)($0.15)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 3/4/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.